Humanized mice for the study of immunoOncology
View/ Open
Author
De la Rochere, Philippe
Guil-Luna, Silvia
Decaudin, Didier
Azar, Georges
Sidhu, Sukhvinder S
Piaggio, Eliane
Publisher
ElsevierDate
2018Subject
Humanized miceImmuno-therapy
Preclinical research
METS:
Mostrar el registro METSPREMIS:
Mostrar el registro PREMISMetadata
Show full item recordAbstract
Immunotherapy is revolutionizing cancer treatment; however, complete responses are achieved in only a small fraction of patients and tumor types. Thus, there is an urgent need for predictive preclinical models to drive rational immunotherapeutic drug development, treatment combinations, and to minimize failures in clinical trials. Humanized mouse models (HIS) have been developed to study and modulate the interactions between immune components and tumors of human origin. In this review, we discuss recent advances in the ‘humanization’ of mouse models to improve the quality of human immune cell reconstitution. We also highlight new insights into the basic mechanisms, and provide a preclinical evaluation of onco-immunotherapies, as well as the limitations thereof, which constitute drivers for the improvement of the models to increase their translational power.